Open Orphan chief to underwrite part of £30m hVivo takeover Friel ready to stump up €3m of fundraising for purchase of British clinical trials firm Ian Guider December 15, 2019 Open Orphan chief executive Cathal Friel: his underwriting will only kick in if the company fails to raise the cash from external investors Sectors Pharma & Med Tech LATEST NEWS17:45Movers and shakers: AIB, Lidl, Pepper Advantage, Collen17:42Mark Anthony Brands grows presence with One Charlemont Square lease17:39Extended East Wall four-bed with parking guides €595,00017:37Hotels take the spotlight as CRE industry rebounds and gears up for a busy second half of 202417:35Just what the doctor ordered: period delight on the River Eske17:35Cut-stone gem in Carlow with AMV under €700k